Gregory A. Demopulos MD - 19 May 2021 Form 4 Insider Report for OMEROS CORP (OMER)

Role
CHAIRMAN, CEO & PRESIDENT, Director
Signature
/s/ Peter B. Cancelmo, Attorney-in-Fact
Issuer symbol
OMER
Transactions as of
19 May 2021
Transactions value $
$-878,291
Form type
4
Filing time
21 May 2021, 18:45:16 UTC
Next filing
17 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMER Common Stock Options Exercise $151,114 +36,857 +1.82% $4.10 2,063,843 19 May 2021 Direct
transaction OMER Common Stock Sale $-629,149 -36,857 -1.79% $17.07* 2,026,986 19 May 2021 Direct F1, F2
transaction OMER Common Stock Options Exercise $151,110 +36,856 +1.82% $4.10 2,063,842 20 May 2021 Direct
transaction OMER Common Stock Sale $-551,366 -36,856 -1.79% $14.96* 2,026,986 20 May 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMER Stock Option (right to buy) Options Exercise $0 -36,857 -25% $0.000000 110,569 19 May 2021 Common Stock 36,857 $4.10 Direct F4
transaction OMER Stock Option (right to buy) Options Exercise $0 -36,856 -33.3% $0.000000 73,713 20 May 2021 Common Stock 36,856 $4.10 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2020 for expiring options. The trading schedule, including sale dates and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 This transaction was executed in multiple trades at prices ranging from $16.92 to $17.60; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
F3 This transaction was executed in multiple trades at prices ranging from $13.87 to $15.27; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
F4 The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011.